Convergence Investment Partners LLC Grows Stock Holdings in Prestige Consumer Healthcare Inc (NYSE:PBH)

Convergence Investment Partners LLC boosted its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 26.2% in the 2nd quarter, Holdings Channel reports. The fund owned 24,409 shares of the company’s stock after purchasing an additional 5,072 shares during the period. Convergence Investment Partners LLC’s holdings in Prestige Consumer Healthcare were worth $917,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Jane Street Group LLC purchased a new stake in Prestige Consumer Healthcare in the 4th quarter worth approximately $483,000. New Mexico Educational Retirement Board lifted its holdings in Prestige Consumer Healthcare by 33.3% in the 1st quarter. New Mexico Educational Retirement Board now owns 12,000 shares of the company’s stock worth $440,000 after buying an additional 3,000 shares in the last quarter. BNP Paribas Arbitrage SA lifted its holdings in Prestige Consumer Healthcare by 107.1% in the 1st quarter. BNP Paribas Arbitrage SA now owns 20,093 shares of the company’s stock worth $737,000 after buying an additional 10,392 shares in the last quarter. Maverick Capital Ltd. acquired a new position in Prestige Consumer Healthcare in the 1st quarter worth $1,218,000. Finally, Legal & General Group Plc raised its stake in shares of Prestige Consumer Healthcare by 9.4% in the 1st quarter. Legal & General Group Plc now owns 68,151 shares of the company’s stock valued at $2,500,000 after purchasing an additional 5,828 shares in the last quarter.

PBH stock traded down $0.39 on Friday, hitting $37.19. 357,825 shares of the company’s stock traded hands, compared to its average volume of 315,282. Prestige Consumer Healthcare Inc has a 1-year low of $27.40 and a 1-year high of $46.12. The stock has a market cap of $1.87 billion, a price-to-earnings ratio of 13.38, a P/E/G ratio of 3.11 and a beta of 0.80. The stock has a fifty day moving average of $38.20 and a 200-day moving average of $39.22. The company has a current ratio of 2.44, a quick ratio of 1.67 and a debt-to-equity ratio of 1.50.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.82 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.74 by $0.08. The business had revenue of $251.20 million during the quarter, compared to the consensus estimate of $239.65 million. Prestige Consumer Healthcare had a net margin of 14.77% and a return on equity of 13.33%. The firm’s quarterly revenue was up 4.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.72 EPS. On average, equities research analysts anticipate that Prestige Consumer Healthcare Inc will post 2.99 earnings per share for the current fiscal year.

PBH has been the subject of a number of recent research reports. TD Securities boosted their price objective on shares of Prestige Consumer Healthcare from $90.00 to $97.00 and gave the company a “hold” rating in a research report on Friday, July 24th. CIBC increased their price objective on shares of Prestige Consumer Healthcare from $86.00 to $88.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Jefferies Financial Group cut shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, April 14th. Zacks Investment Research lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating and set a $42.00 target price for the company. in a research note on Thursday, May 14th. Finally, DA Davidson increased their target price on shares of Prestige Consumer Healthcare from $43.00 to $47.00 in a research note on Wednesday, April 15th. One research analyst has rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company’s stock. Prestige Consumer Healthcare presently has an average rating of “Hold” and a consensus price target of $65.43.

In related news, CEO Ronald M. Lombardi sold 29,593 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $40.00, for a total value of $1,183,720.00. Following the completion of the sale, the chief executive officer now owns 154,630 shares in the company, valued at approximately $6,185,200. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.20% of the stock is currently owned by corporate insiders.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Article: How are the companies in the S&P 500 selected?

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc (NYSE:PBH).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.